CGC vs IIPR: How Canopy Growth Corporation and Innovative Industrial Properties Compare (2026)
Last updated July 2026
Short answer
IIPR is the larger of the two ($1.76B market cap): the incumbent the market prices for continued execution (12.64x forward earnings, beta 1.43). CGC is the smaller challenger ($390.30M), priced similarly on forward earnings (-7.23x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
CGC vs IIPR: the tie-breaker metrics
Same yardstick, side by side (as of July 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | CGC | IIPR | What it tells you |
|---|---|---|---|
| Market cap | $390.30M | $1.76B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | -7.23 | 12.64 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 2.41 | 1.43 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 2% of range | 77% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 0.74 | 0.96 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how CGC and IIPR affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CGC and IIPR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CGC and IIPR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Canopy Growth Corporation (CGC) do?
Canopy Growth Corporation is one of Canada's largest cannabis companies, based in Smiths Falls, Ontario. It sells recreational (adult-use) and medical cannabis in Canada, exports medical cannabis to international markets in Europe and Australia, and owns Storz & Bickel, a maker of premium vaporizer devices. Its revenue comes mainly from selling cannabis flower, pre-rolls, vapes, edibles, and beverages under brands like Tweed and Doja, plus device sales. In fiscal 2026 the company completed its acquisition of MTL Cannabis, a move it says makes it Canada's leading medical-cannabis provider by revenue, and reported that its core cannabis business returned to growth after years of contraction.
What does Innovative Industrial Properties (IIPR) do?
Innovative Industrial Properties, Inc. (NYSE: IIPR) is a real estate investment trust that pioneered the cannabis-focused, sale-leaseback model in the United States. It buys industrial and greenhouse cultivation and processing facilities from state-licensed cannabis operators and leases them back on long-term, triple-net leases, meaning tenants are responsible for property taxes, insurance, and maintenance. Because federally regulated banks have historically been wary of lending to cannabis companies, IIPR stepped in as a specialized source of real estate capital, and rent from these leases is its primary source of income. As of early 2026 the company owned roughly 110 properties totaling around 8.9 million rentable square feet across about 19 states, leased to a few dozen tenants, and has begun describing itself as a diversified REIT with some interest beyond cannabis.
CGC vs IIPR: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- CGC drivers: Core cannabis business back to growth; MTL Cannabis and medical leadership.
- IIPR drivers: High dividend and income appeal; Tenant recovery and re-leasing.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The central risk is that Canopy is still unprofitable in a brutally competitive industry. For IIPR, the dominant risk is tenant concentration and credit quality: IIPR leases to a limited number of cannabis operators, and defaults by its largest tenant and others directly threaten rental income and the dividend, which has at times been uncovered by funds from operations.
CGC or IIPR: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CGC if you believe its drivers more; IIPR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CGC and IIPR guides.
CGC vs IIPR: the full fundamentals
CGC. These figures are qualitative and tied to the asOf date; verify live numbers before acting. Because Canopy is unprofitable, standard earnings multiples do not apply, and the stock trades on revenue trajectory, cash runway, and expectations for cannabis reform rather than on profits. Reported financials are also in Canadian dollars, so US-dollar figures depend on exchange rates. Treat any single quarter with caution: cannabis results swing on pricing, one-time charges, and restructuring.
IIPR. Figures are approximate, tied to the asOf date, and should be verified against the latest filings before acting. For a REIT, the metrics that matter most are funds from operations (FFO) and adjusted FFO relative to the dividend, plus occupancy and rent collection, rather than a standard P/E ratio. A very high dividend yield reflects elevated perceived risk, not just generosity: the market is pricing in the chance of a cut, so treat the headline yield with caution and check the latest FFO and payout figures.
Headline figures (approximate, Jul 2026): CGC shows revenue trend (fy2026) Modest annual growth (roughly mid-single-digit percent), the first sustained return to growth after years of contraction, growth drivers Double-digit gains in Canadian adult-use, Canadian medical, and international cannabis; device sales (Storz & Bickel) were softer, profitability Still net-loss-making, but fiscal 2026 net loss from continuing operations narrowed roughly by half versus the prior year, balance sheet Shifted to a net-cash position after a January 2026 recapitalization, reducing near-term financing risk; IIPR shows portfolio ~110 properties, ~8.9 million rentable square feet, across ~19 states (early 2026), tenants A few dozen tenants (around 36); top tenant and several others have defaulted, pressuring rent, quarterly dividend $1.90 per share declared mid-2026 (held steady), implying a double-digit forward yield, dividend coverage At times not fully covered by funds from operations; coverage hinges on resolving defaults and re-leasing.
The bottom line: CGC vs IIPR
CGC and IIPR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CGC and IIPR exposure against your real portfolio. It is not an investment adviser.
Investing in Canopy Growth Corporation with AI
Connect the broker you already use and ask Walnut's AI how CGC fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between CGC and IIPR?
+
Canopy Growth Corporation is one of Canada's largest cannabis companies, based in Smiths Falls, Ontario. Innovative Industrial Properties, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is CGC or IIPR the better stock?
+
Neither is universally better. IIPR is the larger incumbent; CGC is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, CGC or IIPR?
+
On forward P/E (as of July 2026), CGC trades at -7.23x and IIPR at 12.64x, so CGC is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both CGC and IIPR?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of CGC vs IIPR?
+
CGC: The central risk is that Canopy is still unprofitable in a brutally competitive industry. Canadian adult-use cannabis suffers from oversupply and price compression, which squeezes margins even as volumes grow. The company has a long history of large writedowns (BioSteel, Wana, and others) and heavy share dilution, so existing shareholders have repeatedly been diluted to fund losses. Its US upside through Canopy USA depends on federal reform that has been promised for years without arriving, and remains outside the company's control. Canopy also restated prior-period financials for non-cash technical errors tied to certain US-dollar share-settled warrants. As a small-cap cannabis stock, CGC is highly volatile and sensitive to sentiment, financing conditions, and regulatory headlines, with no guarantee the turnaround reaches sustained profitability. IIPR: The dominant risk is tenant concentration and credit quality: IIPR leases to a limited number of cannabis operators, and defaults by its largest tenant and others directly threaten rental income and the dividend, which has at times been uncovered by funds from operations. The cannabis industry itself faces oversupply, falling wholesale prices, limited banking access, and heavy taxation, all of which weaken tenants' ability to pay. Federal policy is a two-way risk: rescheduling could help, but continued gridlock or unfavorable rules keep operators stressed. A very high dividend yield often signals that the market expects a cut, so the payout may not be safe. As a REIT, IIPR is also sensitive to interest rates, which affect its cost of capital and how income investors value the shares. Its niche focus means fewer diversification cushions than a broad REIT.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CGC or IIPR; figures are approximate and dated (as of July 2026). Verify current data before investing.